Latest DEF 14A proxy statements

Talphera, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 22, 2026, to elect directors and vote on equity plans.

PJT Partners Inc. has released its 2026 Proxy Statement, detailing the agenda for its upcoming Annual Meeting of Shareholders, including director elections, executive compensation approval, and auditor ratification.

Energous Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually.

Evercore Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, detailing proposals including director elections and executive compensation.

Terra Property Trust, Inc. has issued its proxy statement for the upcoming Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors and ratify auditor appointments.

Reeds, Inc. has issued a proxy statement announcing its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, to elect directors, ratify auditors, and approve a new equity incentive plan.

22nd Century Group announces its 2026 Annual Meeting of Stockholders, set for June 11, 2026, to elect a director, approve executive compensation, and ratify auditor appointment.

BlockchAIn Digital Infrastructure, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors and ratify the appointment of its independent auditor.

MediciNova, Inc. has announced its 2026 Annual Meeting of Stockholders will be held on June 23, 2026, proposing a significant increase in authorized common stock.

SuRo Capital Corp. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, detailing proposals for director re-election, executive compensation, and auditor ratification.

Aligos Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, to elect directors, ratify auditor, and vote on ESPP amendment and executive compensation.

Liberty Latin America Ltd. has issued its proxy statement for the 2026 Annual General Meeting of Shareholders, detailing proposals for director elections, auditor appointments, and an incentive plan.

i-80 Gold Corp. has issued its proxy statement detailing the upcoming Annual General Meeting on June 23, 2026, outlining proposals for director elections, auditor appointment, and financial statement review.

Orthofix Medical Inc. has issued its 2026 Proxy Statement detailing the upcoming Annual Meeting of Shareholders on June 10, 2026, outlining proposals for director elections, executive compensation, auditor ratification, and stock purchase plan amendments.

Penumbra, Inc. has announced its 2026 Annual Meeting of Stockholders and a definitive merger agreement with Boston Scientific Corporation.

Sensata Technologies Holding plc has released its 2026 Proxy Statement detailing the upcoming Annual General Meeting of Shareholders on June 9, 2026, outlining proposals for director elections, executive compensation, auditor ratification, and corporate governance matters.

CorMedix Inc. is holding its 2026 Annual Meeting of Stockholders on June 23, 2026, to vote on several proposals, including director elections, executive compensation, auditor ratification, and significant amendments to its corporate charter and preferred stock designations.

Crinetics Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for June 18, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Sensus Healthcare, Inc. has issued its definitive proxy statement, announcing the 2026 Annual Meeting of Stockholders scheduled for May 29, 2026, to elect directors and vote on executive compensation.

Generac Holdings Inc. has filed its 2026 Proxy Statement, detailing the agenda for its Annual Meeting of Stockholders on June 11, 2026, including director elections, auditor ratification, and advisory executive compensation approval.

Fidelity National Financial, Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on June 10, 2026, to elect directors and vote on key corporate matters.

Axogen, Inc. announced its 2026 Annual Meeting of Shareholders will be held virtually on June 23, 2026, to elect directors, ratify auditors, and vote on executive compensation.

SANUWAVE Health, Inc. has announced its annual stockholder meeting for June 11, 2026, to vote on director elections, auditor ratification, and executive compensation.

Candel Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 23, 2026, to elect directors and ratify auditor appointment.

Cypherpunk Technologies Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors, vote on executive compensation, and ratify auditor appointments.

IDEAYA Biosciences, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Xometry announces record $687 million in revenue for 2025, a 26% year-over-year increase, alongside significant Adjusted EBITDA growth and marketplace gross margin expansion.

Black Diamond Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 26, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Adicet Bio, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, with key proposals including director elections and executive compensation.

SenesTech, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, vote on executive compensation, and approve an amendment to its 2018 Equity Incentive Plan.